女性对骨质疏松症、骨折风险及药物治疗的看法:一项横断面研究
该横断面研究通过Facebook广告招募加拿大≥45岁女性填写电子问卷,评估早期绝经女性对骨丢失、骨折风险及预防性药物治疗的看法。在98名早期绝经受访者中,42%担心未来骨折,47%愿意开始药物预防骨折,54%愿意开始药物预防骨丢失,与年长女性应答相当。
要点
- 早期绝经女性中42%担心未来骨折,36%对既往骨密度扫描结果感到担忧。
- 早期绝经女性中47%愿意开始药物预防骨折,54%愿意开始药物预防骨丢失。
- 早期绝经女性与年长女性对骨丢失、骨折风险及药物治疗的看法相当。
核心结论
- 绝经女性关注骨丢失和骨折,许多女性会考虑早期绝经药物治疗,以维护骨骼健康和降低骨折风险。
研究设计与样本
- 横断面研究,通过Facebook广告招募加拿大≥45岁女性完成电子问卷,2033名女性回应,1195名符合条件者开始调查,966名完成。
- 主要结局为早期绝经(末次月经≤5年)受访者中担心骨丢失和骨折的比例,次要结局为早期绝经女性愿意接受药物干预预防骨丢失或未来骨折的比例。
- 比较早期绝经女性与年长女性(末次月经>5年)的应答。
主要发现
- 早期绝经受访者(N=98)中38名(42%)担心未来骨折,25名有既往骨密度扫描者中9名(36%)担心其结果。
- 早期绝经受访者中42名(47%)愿意开始药物预防骨折,48名(54%)愿意开始药物预防骨丢失。
- 早期绝经女性与年长女性的应答相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: We assessed women's perspectives regarding early preventative therapy for osteoporosis. More than a third of early menopausal women were concerned about bone loss and future fractures, and approximately half were willing to take an intravenous or oral bisphosphonate around the time of menopause to preserve bone health. PURPOSE: Bisphosphonate medications can prevent the substantial bone loss that occurs during early menopause, but little is known about whether women would accept bisphosphonate treatment at this time in their life, when imminent fracture risk is low. We assessed women's perspectives regarding bone loss, fracture risk, and preventative pharmacotherapy in early menopause. METHODS: In this cross-sectional study, Canadian women aged ≥ 45 years were recruited via Facebook advertisement to complete an electronic survey. Primary outcome was the proportion of early menopausal respondents (≤ 5 years since final menstrual period) who were worried about bone loss and fractures. Secondary outcomes were the proportion of early menopausal women willing to accept pharmacologic intervention aimed at preventing either bone loss or future fractures. We compared responses between early menopausal women and older women (> 5 years since final menstrual period). RESULTS: 2033 women responded to the Facebook advertisement, 1195 eligible women (aged: 45 to 89 years) started the survey, and 966 completed it. Among early menopausal respondents (N = 98), 38 (42%) were worried about future fractures and 9 of 25 (36%) who had a prior bone mineral density scan were worried about their results. A total of 42 (47%) were willing to start medication to prevent fractures, and 48 (54%) would start medication to prevent bone loss. Responses were comparable between early menopausal women and older women. CONCLUSION: Menopausal women are concerned about bone loss and fractures. Many women would consider early menopausal pharmacotherapy, with the goals of preserving bone health and lowering their risk of fractures.
引用
- Billington EO, Miyagishima RC, Hasselaar C, et al. Women's perspectives regarding osteoporosis, fracture risk, and pharmacologic treatment: a cross-sectional study. Osteoporos Int. 2023. PMID: 37608123. doi:10.1007/s00198-023-06890-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。